Results 81 to 90 of about 12,770 (237)

In-Lab Upfront Use of Tirofiban May Reduce the Occurrence of No-Reflow During Primary Percutaneous Coronary Intervention. A Pilot Randomized Study

Arquivos Brasileiros de Cardiologia
Background: Despite successful opening of culprit coronary artery, myocardial reperfusion does not always follows primary percutaneous coronary intervention (PPCI).
Igor Matos Lago, Gustavo Caires Novaes, André Vannucchi Badran, Rafael Brolio Pavão, Ricardo Barbosa, Geraldo Luiz de Figueiredo, Moysés de Oliveira Lima Filho, Jorge Luiz Haddad, André Schmidt, José Antônio Marin Neto   +9 more
doaj   +1 more source

Elucidating the role of Staphylococcus epidermidis serine-aspartate repeat protein G in platelet activation. [PDF]

, 2009
BACKGROUND: Staphylococcus epidermidis is a commensal of the human skin that has been implicated in infective endocarditis and infections involving implanted medical devices. S. epidermidis induces platelet aggregation by an unknown mechanism.
Arasu, S, Brennan, Marian P, Chubb, Anthony J, Cox, Dermot, Devocelle, Marc, Foster, T J, Loughman, A   +6 more
core   +2 more sources

Association Between Early Spontaneous Post‐Thrombectomy Blood Pressure Reduction and Clinical Outcomes in Large Vessel Occlusion Stroke

Brain and Behavior, Volume 15, Issue 7, July 2025.
Early spontaneous systolic blood pressure (SBP) reduction after thrombectomy—without pharmacologic intervention—was independently associated with favorable outcomes in patients with anterior circulation large vessel occlusion stroke. Combining ΔSBP with nadir SBP within 30 min post‐procedure significantly improved predictive accuracy for 90‐day ...
Jianwen Bu, Guosen Bu, Yang Zhang
wiley   +1 more source

A Systematic Invasive Strategy in non-ST Elevation Acute Coronary Syndromes: Is Age a Limiting Factor? [PDF]

, 2005
Introdução: A estratégia terapêutica sistematicamente invasiva das síndromes coronárias agudas (SCA) é actualmente aceite como segura e eficaz, sendo crescentes as evidências da sua superioridade em relação a uma atitude conservadora.
Cruz Ferreira, R, Feliciano, J, Ferreira, ML, Fiarresga, A, Gonçalves, JM, Pelicano, NJ, Quininha, J, Sousa, L   +7 more
core  

Pneumonitis and pulmonary haemorrhage after acute myocardial infarction [PDF]

, 2015
A 55-year-old man presented with acute ST-elevation myocardial infarction. He received rescue angioplasty with one drug eluting stent. He developed marked breathlessness and haemoptysis two days later.
Millar, Colin GM, Noman, Awsan, Parasuraman, Sathish K, Teo, Alison IC   +3 more
core   +1 more source

The FRED‐X Flow Diverter—An Australian Experience

Journal of Medical Imaging and Radiation Oncology, Volume 69, Issue 4, Page 484-490, June 2025.
ABSTRACT Background The FRED X flow diverter features antithrombotic surface treatment to reduce thrombogenicity. This study evaluated the safety and efficacy of FRED X in treating intracranial aneurysms in the Australian setting. Methods Clinical, procedural and imaging data were retrospectively reviewed for a consecutive series of patients at a ...
Peter Shuangyue Tan, Charles Li, Cameron Williams, Winston Chong, Carlos Chung, Conor Houlihan, Anoop Madan   +6 more
wiley   +1 more source

Perioperative antiplatelet therapy: the case for continuing therapy in patients at risk of myocardial infarction [PDF]

, 2017
Recent clinical data show that the risk of coronary thrombosis after antiplatelet drugs withdrawal is much higher than that of surgical bleeding if they are continued.
Chassot, P.-G, Delabays, A., Spahn, D. R.   +2 more
core  

Association Between Argatroban and Outcomes of Branch Atheromatous Disease: A Propensity‐Matched Analysis From MRI‐Based Study

CNS Neuroscience &Therapeutics, Volume 31, Issue 6, June 2025.
In patients with branch atheromatous disease‐related stroke, argatroban was not associated with excellent outcome (mRS 0–1) at 90 days, though it was widely used. The risks and benefits of argatroban need reevaluation in this patient population. ABSTRACT Background and Purpose Argatroban is widely used for patients with acute branch atheromatous ...
Shengde Li, Haizhou Hu, Yaping Zhou, Ping Zhang, Guofang Chen, Hongying Bai, Bin Liu, Lixin Zhou, Yicheng Zhu, Bin Peng, Jun Ni, on behalf of BAD‐study investigators   +11 more
wiley   +1 more source

The role of intravenous tirofiban in patients undergoing endovascular treatment for acute intracranial atherosclerotic occlusion

Journal of Stroke and Cerebrovascular Diseases
BACKGROUND AND PURPOSE: Previous reports regarding the impact of tirofiban on patients undergoing endovascular treatment for acute ischemic stroke have shown inconsistencies.
Zhiping Bu, MD, Dapeng Sun, MD, Xiaoli Zhang, PhD, Ning Ma, MD, Feng Gao, MD, Dapeng Mo, MD, Qingwei Meng, MD, Zhongrong Miao, MD   +7 more
doaj   +1 more source

Platelet Inhibition in Percutaneous Coronary Interventions [PDF]

, 2018
: Mechanical disruption of atherosclerotic plaques at the time of percutaneous coronary intervention (PCI) is a potent stimulus for arterial thrombosis.
Roffi, Marco, Wyss, Christophe
core